CanSino Biologics Inc.
HKEX:6185.HK
30.95 (HKD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -1,978.884 | -1,184.001 | 1,907.086 | -407.046 | -156.766 | -138.281 | -64.45 | -49.851 |
| Depreciation & Amortization
| 269.053 | 196.36 | 88.542 | 31.817 | 22.473 | 12.019 | 8.489 | 6.402 |
| Deferred Income Tax
| 0 | 0 | -43.585 | -7.796 | -0.128 | -12.338 | -11.58 | -1.528 |
| Stock Based Compensation
| 9.543 | 10.083 | 9.802 | 17.511 | 21.518 | 15.78 | 7.309 | 10 |
| Change In Working Capital
| -156.955 | -1,478.956 | 84.308 | -100.773 | -12.815 | 0.378 | 4.081 | 4.238 |
| Accounts Receivables
| 265.968 | -495.796 | -419.935 | -107.76 | -8.593 | -7.956 | 0 | 1.941 |
| Inventory
| -214.35 | -604.019 | -706.392 | -144.157 | -8.085 | -6.87 | -1.624 | 0 |
| Accounts Payables
| 0 | 495.796 | 419.935 | 107.76 | 8.593 | 0 | 0 | 0 |
| Other Working Capital
| 11.2 | -874.937 | 790.7 | 43.384 | -4.73 | 7.248 | 5.705 | 2.314 |
| Other Non Cash Items
| -75.769 | 568.915 | -31.596 | -3.102 | -44.471 | -1.196 | -0.15 | -3.644 |
| Operating Cash Flow
| -916.252 | -1,887.599 | 2,014.557 | -469.389 | -170.189 | -123.638 | -56.301 | -34.383 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -610.47 | -1,075.013 | -1,203.136 | -270.774 | -116.948 | -160.674 | -185.892 | -126.08 |
| Acquisitions Net
| -110.038 | -3.25 | -64.879 | -0.886 | -6.893 | 11.251 | -21.423 | 0 |
| Purchases Of Investments
| -8,094.871 | -12,361.495 | -8,479.048 | -6,287.01 | -1,664.652 | -1,448.2 | -2,081.65 | -251 |
| Sales Maturities Of Investments
| 8,365.42 | 12,212.117 | 7,121.772 | 6,255.616 | 967.865 | 1,724.529 | 1,784.137 | 188.667 |
| Other Investing Activites
| 8.025 | 35.686 | 94.021 | 120.341 | 22.858 | -9.281 | 43.338 | 14.87 |
| Investing Cash Flow
| -441.622 | -1,191.955 | -2,531.27 | -182.713 | -797.77 | 117.625 | -461.49 | -173.543 |
| Financing Activities: | ||||||||
| Debt Repayment
| -69.28 | -1,365.699 | -160 | -22.493 | -7.302 | -41.667 | -39.004 | -69.329 |
| Common Stock Issued
| 0 | 0 | 0 | 4,983.776 | 1,127.77 | 17.486 | 450 | 0 |
| Common Stock Repurchased
| 0 | -150.169 | 0 | 0 | 7.302 | 0 | 0 | 0 |
| Dividends Paid
| -3.628 | -193.932 | -14.098 | -6.691 | -8.783 | -7.593 | -4.632 | -0.336 |
| Other Financing Activities
| 16.984 | 2,564.402 | 1,734.02 | 4,970.222 | -28.161 | 35.162 | 39.004 | 151.151 |
| Financing Cash Flow
| -7.582 | 854.602 | 1,559.922 | 4,941.038 | 1,090.826 | 45.055 | 484.372 | 150.815 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 20.287 | 160.764 | -33.782 | -27.36 | 21.725 | 0.092 | -0.882 | 2.685 |
| Net Change In Cash
| -1,345.169 | -2,064.188 | 1,009.427 | 4,244.056 | 144.592 | 39.134 | -34.301 | -54.426 |
| Cash At End Of Period
| 2,046.099 | 3,391.268 | 5,455.456 | 4,446.029 | 201.973 | 57.381 | 18.247 | 52.548 |